CLEVELAND, Ohio (July 7, 2022)—In the 20 years since the Women’s Health Initiative, hormone therapy remains one of the most hotly debated topics around the treatment of such bothersome menopause symptoms as hot flashes. In an effort to provide the most up-to-date, scientifically based information on the topic, The North American Menopause Society (NAMS) has issued its 2022 Hormone Therapy Position Statement that will be published today in Menopause , the official NAMS journal.
“NAMS is pleased to announce the release of its updated Position Statement on hormone therapy,” says Dr. Stephanie S. Faubion, NAMS Medical Director and lead of the Position Statement Advisory Panel. “Since our last Position Statement on hormone therapy published in 2017, there have been important additions that further clarify the balance of risks and benefits of hormone therapy options for menopause symptoms. NAMS has reviewed existing data on hormone therapies published after the last Position Statement and, after exhaustive research and review of the literature, we have found that what hasn’t changed is that hormone therapy remains the most effective treatment for vasomotor symptoms and the genitourinary syndrome of menopause and has been shown to prevent bone loss and fracture.”
Highlights from the NAMS 2022 Hormone Therapy Position Statement include
“The 2022 Hormone Therapy Position Statement of The North American Menopause Society” has been endorsed by more than 20 well-respected international organizations. It can be viewed on the NAMS website [link to https://www.menopause.org/docs/default-source/professional/nams-2022-hormone-therapy-position-statement.pdf ]. A patient-education piece , [link to https://www.menopause.org/docs/default-source/professional/menonote-deciding-about-ht-2022.pdf ] “Deciding About Hormone Therapy Use,” part of the NAMS MenoNote series, is also available on the website. This valuable handout simplifies the data in the new NAMS Position Statement for women trying to make decisions about using hormone therapy.
For more information about menopause and healthy aging, visit www.menopause.org .
Founded in 1989, The North American Menopause Society (NAMS) is North America’s leading nonprofit organization dedicated to promoting the health and quality of life of all women during midlife and beyond through an understanding of menopause and healthy aging. Its multidisciplinary membership of 2,000 leaders in the field—including clinical and basic science experts from medicine, nursing, sociology, psychology, nutrition, anthropology, epidemiology, pharmacy, and education—makes NAMS uniquely qualified to serve as the definitive resource for health professionals and the public for accurate, unbiased information about menopause and healthy aging. To learn more about NAMS, visit www.menopause.org .
Menopause
Literature review
People
NAMS Position Statement: The 2022 hormone therapy position statement of The North American Menopause Society
There was no commercial support.